Resmed Inc [RMD] stock is trading at $236.19, up 2.85%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMD shares have gain 2.43% over the last week, with a monthly amount drifted -5.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Neutral rating on January 10, 2025, and set its price target to $252. On December 13, 2024, Stifel initiated with a Hold rating and assigned a price target of $250 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $280 on September 24, 2024. Wolfe Research downgraded its rating to a Underperform but $180 remained the price target by the analyst firm on September 18, 2024. Needham downgraded its rating to Hold for this stock on September 04, 2024. In a note dated June 25, 2024, Oppenheimer downgraded an Perform rating on this stock.
Resmed Inc [RMD] stock has fluctuated between $170.56 and $263.05 over the past year. Currently, Wall Street analysts expect the stock to reach $238.8 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $236.19 at the most recent close of the market. An investor can expect a potential return of 1.11% based on the average RMD price forecast.
Analyzing the RMD fundamentals
Resmed Inc [NYSE:RMD] reported sales of 4.93B for the trailing twelve months, which represents a growth of 10.26%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.32%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.25 and Total Capital is 0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 231.52 points at the first support level, and at 226.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 238.59, and for the 2nd resistance point, it is at 240.98.
Ratios To Look Out For
For context, Resmed Inc’s Current Ratio is 3.33. In addition, the Quick Ratio stands at 2.29 and the Cash Ratio stands at 0.61. Considering the valuation of this stock, the price to sales ratio is 7.04, the price to book ratio is 6.60 and price to earnings (TTM) ratio is 27.90.
Transactions by insiders
Recent insider trading involved Sandercock Brett, Chief Financial Officer, that happened on Feb 10 ’25 when 1000.0 shares were sold. Chief Executive Officer, Farrell Michael J. completed a deal on Feb 07 ’25 to sell 8009.0 shares. Meanwhile, Officer Sandercock Brett bought 1000.0 shares on Feb 10 ’25.
